Michael J Stocks (Michael Stocks)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 35

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

ACS macro letters

Science signaling

University of Nottingham

University of Southampton (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Nottingham Apr 02 2012

United Kingdom

Associate Professor :: Pharmacy

Education History

University of Southampton Sep 01 1987 - Oct 01 1990

United Kingdom

PHD :: Chemistry

Publications

Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Rebecca Knight, Laura E Kilpatrick, Stephen J Hill, Michael J Stocks
Design, Synthesis, and Evaluation of a New Chemotype Fluorescent Ligand for the P2Y 2 Receptor. ACS medicinal chemistry letters 15 (7) (2024)
Di Wang, Gerald Pattenden, Kam Loon Fow, Michael J Stocks, Jonathan D Hirst, Bencan Tang
Theoretical Study on the Biosynthesis of the Mandapamates: Mechanistic Insights Using Density Functional Theory. The Journal of organic chemistry (2024)
Matthew Allison, Rebecca L Davie, Adrian J Mogg, Sally L Hampton, Jonas Emsley, Michael J Stocks
Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein. ACS medicinal chemistry letters 15 (4) (2024)
Rebecca Knight, Laura E Kilpatrick, Stephen J Hill, Michael J Stocks
Design, Synthesis, and Evaluation of a New Chemotype Fluorescent Ligand for the P2Y 2 Receptor. ACS medicinal chemistry letters 15 (7) (2024)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Jean-Frédéric Dubern, Shaun N Robertson, Simone Lucanto, Zoe Markham-Lee, Tomás Sou, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Nigel Halliday, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design, Synthesis, and Evaluation of New 1 H -Benzo[ d ]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of medicinal chemistry 67 (2) (2024)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Jean-Frédéric Dubern, Shaun N Robertson, Simone Lucanto, Zoe Markham-Lee, Tomás Sou, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Nigel Halliday, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design, Synthesis, and Evaluation of New 1 H -Benzo[ d ]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of medicinal chemistry 67 (2) (2024)
Matthew Allison, Rebecca L Davie, Adrian J Mogg, Sally L Hampton, Jonas Emsley, Michael J Stocks
Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein. ACS medicinal chemistry letters 15 (4) (2024)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Jean-Frédéric Dubern, Shaun N Robertson, Simone Lucanto, Zoe Markham-Lee, Tomás Sou, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Nigel Halliday, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design, Synthesis, and Evaluation of New 1 H -Benzo[ d ]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of medicinal chemistry 67 (2) (2024)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Jean-Frédéric Dubern, Shaun N Robertson, Simone Lucanto, Zoe Markham-Lee, Tomás Sou, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Nigel Halliday, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design, Synthesis, and Evaluation of New 1 H -Benzo[ d ]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of medicinal chemistry 67 (2) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Matthew Allison, Rebecca L Davie, Adrian J Mogg, Sally L Hampton, Jonas Emsley, Michael J Stocks
Discovery of α-Amidobenzylboronates as Highly Potent Covalent Inhibitors of Plasma Kallikrein. ACS medicinal chemistry letters 15 (4) (2024)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Jean-Frédéric Dubern, Shaun N Robertson, Simone Lucanto, Zoe Markham-Lee, Tomás Sou, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Nigel Halliday, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design, Synthesis, and Evaluation of New 1 H -Benzo[ d ]imidazole Based PqsR Inhibitors as Adjuvant Therapy for Pseudomonas aeruginosa Infections. Journal of medicinal chemistry (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Carl W White, Simon Platt, Laura E Kilpatrick, Natasha Dale, Rekhati S Abhayawardana, Sebastian Dekkers, Nicholas D Kindon, Barrie Kellam, Michael J Stocks, Kevin D G Pfleger, Stephen J Hill
CXCL17 is an allosteric inhibitor of CXCR4 through a mechanism of action involving glycosaminoglycans. Science signaling 17 (828) (2024)
Fadi Soukarieh, Pratik Gurnani, Manuel Romero, Nigel Halliday, Michael J Stocks, Cameron Alexander, Miguel Cámara
Design of Quorum Sensing Inhibitor-Polymer Conjugates to Penetrate Pseudomonas aeruginosa Biofilms. ACS macro letters (2023)
Fadi Soukarieh, Pratik Gurnani, Manuel Romero, Nigel Halliday, Michael J Stocks, Cameron Alexander, Miguel Cámara
Design of Quorum Sensing Inhibitor-Polymer Conjugates to Penetrate Pseudomonas aeruginosa Biofilms. ACS macro letters 12 (3) (2023)
Fadi Soukarieh, Pratik Gurnani, Manuel Romero, Nigel Halliday, Michael J Stocks, Cameron Alexander, Miguel Cámara
Design of Quorum Sensing Inhibitor-Polymer Conjugates to Penetrate Pseudomonas aeruginosa Biofilms. ACS macro letters 12 (3) (2023)
Fadi Soukarieh, Pratik Gurnani, Manuel Romero, Nigel Halliday, Michael J Stocks, Cameron Alexander, Miguel Cámara
Design of Quorum Sensing Inhibitor-Polymer Conjugates to Penetrate Pseudomonas aeruginosa Biofilms. ACS macro letters 12 (3) (2023)
Sebastian Dekkers, Dehan Comez, Noemi Karsai, Marta Arimont-Segura, Meritxell Canals, Birgit Caspar, Chris de Graaf, Laura E Kilpatrick, Rob Leurs, Barrie Kellam, Stephen J Hill, Stephen J Briddon, Michael J Stocks
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3). ACS medicinal chemistry letters 15 (1) (2023)
Sebastian Dekkers, Birgit Caspar, Joëlle Goulding, Nicholas D Kindon, Laura E Kilpatrick, Leigh A Stoddart, Stephen J Briddon, Barrie Kellam, Stephen J Hill, Michael J Stocks
Small-Molecule Fluorescent Ligands for the CXCR4 Chemokine Receptor. Journal of medicinal chemistry (2023)
Sebastian Dekkers, Dehan Comez, Noemi Karsai, Marta Arimont-Segura, Meritxell Canals, Birgit Caspar, Chris de Graaf, Laura E Kilpatrick, Rob Leurs, Barrie Kellam, Stephen J Hill, Stephen J Briddon, Michael J Stocks
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3). ACS medicinal chemistry letters 15 (1) (2023)
Fadi Soukarieh, Pratik Gurnani, Manuel Romero, Nigel Halliday, Michael J Stocks, Cameron Alexander, Miguel Cámara
Design of Quorum Sensing Inhibitor-Polymer Conjugates to Penetrate Pseudomonas aeruginosa Biofilms. ACS macro letters 12 (3) (2023)
Fadi Soukarieh, Pratik Gurnani, Manuel Romero, Nigel Halliday, Michael J Stocks, Cameron Alexander, Miguel Cámara
Design of Quorum Sensing Inhibitor-Polymer Conjugates to Penetrate Pseudomonas aeruginosa Biofilms. ACS macro letters (2023)
Rebecca L Davie, Hannah J Edwards, D Michael Evans, Simon T Hodgson, Michael J Stocks, Alun J Smith, Louise J Rushbrooke, Stephen J Pethen, Michael B Roe, David E Clark, Paul A McEwan, Sally L Hampton
Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema. Journal of medicinal chemistry 65 (20) (2022)
Jack Ayre, Joanna M Redmond, Giovanni Vitulli, Laura Tomlinson, Richard Weaver, Eleonora Comeo, Cynthia Bosquillon, Michael J Stocks
Design, Synthesis, and Evaluation of Lung-Retentive Prodrugs for Extending the Lung Tissue Retention of Inhaled Drugs. Journal of medicinal chemistry 65 (14) (2022)
Fadi Soukarieh, Alaa Mashabi, William Richardson, Eduard Vico Oton, Manuel Romero, Shaun N Roberston, Scott Grossman, Tomas Sou, Ruiling Liu, Nigel Halliday, Irena Kukavica-Ibrulj, Roger C Levesque, Christel A S Bergstrom, Barrie Kellam, Jonas Emsley, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Cámara
Design and Evaluation of New Quinazolin-4(3H)-one Derived PqsR Antagonists as Quorum Sensing Quenchers in Pseudomonas aeruginosa. ACS infectious diseases 7 (9) (2021)
Sean Conroy, Nicholas D Kindon, Jacqueline Glenn, Leigh A Stoddart, Richard J Lewis, Stephen J Hill, Barrie Kellam, Michael J Stocks
Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925. Journal of medicinal chemistry 61 (7) (2018)
Fadi Soukarieh, Paul Williams, Michael J Stocks, Miguel Cámara
Pseudomonas aeruginosa Quorum Sensing Systems as Drug Discovery Targets: Current Position and Future Perspectives. Journal of medicinal chemistry 61 (23) (2018)
Fadi Soukarieh, Eduard Vico Oton, Jean-Frédéric Dubern, Janice Gomes, Nigel Halliday, Maria de Pilar Crespo, Jonathan Ramírez-Prada, Braulio Insuasty, Rodrigo Abonia, Jairo Quiroga, Stephan Heeb, Paul Williams, Michael J Stocks, Miguel Camara
In Silico and in Vitro-Guided Identification of Inhibitors of Alkylquinolone-Dependent Quorum Sensing in Pseudomonas aeruginosa. Molecules (Basel, Switzerland) 23 (2) (2018)
Francesca Citossi, Thomas Smith, Jong Bong Lee, Joel Segal, Pavel Gershkovich, Michael J Stocks, Tracey D Bradshaw, Barrie Kellam, Maria Marlow
Self-Assembling Benzothiazole-Based Gelators: A Mechanistic Understanding of in Vitro Bioactivation and Gelation. Molecular pharmaceutics 15 (4) (2018)
Aimie E Garces, Michael J Stocks
Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective. Journal of medicinal chemistry 62 (10) (2018)
Sean Conroy, Nicholas D Kindon, Jacqueline Glenn, Leigh A Stoddart, Richard J Lewis, Stephen J Hill, Barrie Kellam, Michael J Stocks
Correction to Synthesis and Evaluation of the First Fluorescent Antagonists of the Human P2Y2 Receptor Based on AR-C118925. Journal of medicinal chemistry 61 (9) (2018)
Carolin Schwehm, Barrie Kellam, Aimie E Garces, Stephen J Hill, Nicholas D Kindon, Tracey D Bradshaw, Jin Li, Simon J F Macdonald, James E Rowedder, Leigh A Stoddart, Michael J Stocks
Design and Elaboration of a Tractable Tricyclic Scaffold To Synthesize Druglike Inhibitors of Dipeptidyl Peptidase-4 (DPP-4), Antagonists of the C-C Chemokine Receptor Type 5 (CCR5), and Highly Potent and Selective Phosphoinositol-3 Kinase δ (PI3Kδ) Inhibitors. Journal of medicinal chemistry 60 (4) (2017)

Michael J Stocks.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Stocks)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael J Stocks (Michael Stocks)